[PDF] Top 20 Refractory relapsing polychondritis: challenges and solutions

... in relapsing polychondri- ...of relapsing polychondritis occurred within 2 months to 4 years in patients treated for ankylosing spondylitis with anti-TNF α , requiring the use of corticosteroids to ... See full document

... Abstract: Pilon fractures include a wide range of complexity. The timing and type of de fi nitive fi xation is dictated by the soft tissue injury and energy imparted to the fracture. One should have a low threshold for ... See full document

... for refractory ascites in liver cirrhosis, most patients have to wait for a long period of time or even die before the operation because of absolute organ ...for refractory ascites, whether by large-volume ... See full document

... 230 South Asian Journal of Multidisciplinary Studies (SAJMS) ISSN:2349-7858:Volume 2 Issue 3.. “Where you get a situation which involves the use of some special skill or competence, then[r] ... See full document

... a recent cases series, lesional skin biopsy sample was taken from three patients affected by refractory PRP and mRNA expression of proinflammatory innate and T-cell-derived cytokines were measured. Gene expression ... See full document

... Abstract: Cryoglobulinemia is thought to be a rare condition. It may be an isolated disorder or secondary to a particular disease. According to immunoglobulin composition, cryoglobulinemia is classified into three types. ... See full document

... Combination therapy of ADA plus intensive GMA, or IFX plus AZA, is considered to be useful for the treatment of patients with refractory CD due to the high rate of induction of remission. These therapeutic ... See full document

... mechanisms for refractory GERD include functional bowel disorders, weakly acidic reflux, and residual acid. Factors related to metabolism and bioavailability play a limited role in PPI failure. GERD-like symptoms ... See full document

... B cells play a principal role in the pathogenesis of LN and are therefore attractive therapeutic targets. Rituximab (RTX) is a chimeric mouse-human monoclonal antibody directed against the B-cell surface molecule CD20. ... See full document

... treatment refractory when discussing clinical infections, as there may be many reasons for treatment failure, one of them being that the infecting Giardia isolate is truly drug ... See full document

... Relapsing polychondritis (RP) is a disease of unknown etiology characterized by recurrent non-infectious in- flammation of cartilaginous and connective ... See full document

... with relapsing polychondritis in an attempt to define a potential immunopathologic role for degradation constituents of cartilage in the causation and/or perpetuation of the inflammation ... See full document

... [18] A. Sharma, P. Bambery, A. Wanchu et al., “Relapsing polychon- dritis in North India: a report of 10 patients,” Scandinavian Journal of Rheumatology, vol. 36, no. 6, pp. 462–465, 2007. [19] A. Salihoglu, E. ... See full document

... PD solutions has long been a theoretical concern, recent evidence suggests that all first-line IP antibiotics are stable for routine clinical use, including pre-injection by helpers [12, ... See full document

... The cytokine data in this study agree with the above observations. Both transgenic strains produced high lev- els of IL-18, a proinflammatory cytokine suggested in pathogenesis of RA (34). Both strains produced similar ... See full document

... Abstract: We were presented with two cases of relapsing polychondritis (RP) associated with different types of ocular inflammation. The first case was a 35-year-old man who had bilateral hyperemic ... See full document

... We showed that IL-10-deficient mice immunized with CII develop a more severe disease than their heterozygous littermates, while they are protected from antibody-transferred arthritis ind[r] ... See full document

... remained refractory, and only five patients were finally considered candidates for ...when relapsing after a prior ASCT were consolidated with nonmyeloablative allogeneic stem cell transplantation (three ... See full document

... cytokines like interleukin-5 (IL-5) function as growth fac- tors for eosinophils [7] and eotaxin-3 has been identified as an eosinophil recruitment factor [8]. Targeting interleukin-5 with mepolizumab is promising for ... See full document

... RP is treated with several therapeutic methods according to different manifestations of the disease. Less severe symptoms like moderate auricular, nasal chondritis and arthralgia are usu- ally treated with nonsteroid ... See full document